Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies
Simone Hettmer(Martin Luther University Halle-Wittenberg), Charles Keller(Children's Cancer Therapy Development Institute), Grace K. Pavlath, Corrine M Linardic, Javed Khan(Kent State University), Ranadip Pal(Texas Tech University), DDW Cornelison, Amy J. Wagers(Harvard University), Andrew N. Billin(Gilead Sciences (United States)), Beat W. Schäfer(University Children's Hospital Zurich), Rossella Rota(Bambino Gesù Children's Hospital), Terence A. Partridge(Institute of Child Health), Andrea Hayes‐Jordan(The University of Texas MD Anderson Cancer Center), Lee J. Helman(American Osteopathic Association), F. G. Barr, Peter J. Houghton(The University of Texas at San Antonio Health Science Center), Leonard H. Wexler(Memorial Sloan Kettering Cancer Center), A. R. Ehrlich, Barry C. Stillman, Denis C. Guttridge(Medical University of South Carolina), Janet Shipley(Institute of Cancer Research), Zhiyong Li(Jingdezhen University), David M. Langenau(Massachusetts General Hospital)
Cited by 83
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
|Science|2015|1.1k